The MRCP Part 1 is two papers of 100 best-of-five questions, three hours each, sat on the same day: 200 marks drawn from the whole breadth of internal medicine. Faced with that, most candidates do the natural thing and revise what they find interesting, or what they happen to be rotating through. The blueprint does not reward that. It has its own weighting, some of the heaviest-scoring content is not a specialty at all, and the gap between what you have revised and what the paper actually asks is where most failed attempts live.
Key takeaways
- The exam is 200 best-of-five questions across two three-hour papers on a single day.
- The blueprint weights specialties unequally, and the distribution is published: read it before planning.
- Clinical sciences is the single largest block, and it is the one no rotation ever teaches you.
- Coverage must be established before adaptive practice, because an engine cannot target what you have never attempted.
- Protect the small domains, because four or eight marks are still marks and they are cheap to secure.
The blueprint is public, and it is not flat
Start by reading the actual blueprint published by the Federation, because a surprising number of candidates never do. It sets out the likely number of questions under each broad topic heading, and the distribution is distinctly uneven.
Some specialties carry substantial weight, roughly fifteen questions each across the two papers: cardiology, endocrinology, gastroenterology, neurology, respiratory medicine, rheumatology, nephrology, infectious diseases, haematology and oncology. Others carry far less: ophthalmology sits in low single figures, and dermatology and psychiatry in high single figures.
That distribution should shape your plan directly. A candidate who spends three weeks on dermatology because they find it satisfying, and a fortnight on cardiology because it is hard, has inverted the paper's own priorities. This is not an argument for ignoring the small domains, and I will come back to why. It is an argument for knowing the weights before you allocate the hours.
The largest block is the one nobody owns
Here is the finding that changes most revision plans. The single largest block on the blueprint is clinical sciences, and it is orphaned.
Clinical sciences bundles the material that underpins medicine rather than any one specialty: pharmacology, including mechanisms, kinetics and important interactions; statistics and epidemiology, including sensitivity and specificity, predictive values and study design; genetics; immunology; cell and molecular biology; physiology; and biochemistry. It carries more marks than any individual clinical specialty.
And it belongs to no one. No rotation teaches it. No consultant asks about it on a ward round. It does not appear in your day job, which is precisely why candidates who are competent, working physicians arrive at the exam having barely touched the biggest single component of it. If you take one structural decision from this article, make it this: give clinical sciences the time its weight deserves, and start early, because the material decays and is easily crowded out by the clinical revision that feels more like real medicine.
Coverage before optimisation
The sequence matters. Begin in Standard mode, sampling broadly across the whole blueprint rather than following interest, and record two separate figures for each domain: your accuracy, and your exposure.
The exposure column is the one that catches people. A domain where you have scored forty per cent across forty questions is a known weakness, and you can act on it. A domain where you have answered five questions is not a strength, it is an unknown, and unknowns are where exam-day surprises come from. Most candidates, when they finally build this table, discover that their apparent weak areas are simply the areas they have actually sampled, while whole sections of the blueprint sit unexamined.
Only once you have representative coverage does adaptive practice earn its place, because an adaptive engine can only target weaknesses it has observed. Run it too early and you get an efficient, well-targeted tour of your comfort zone.
Protect the small domains anyway
The temptation, having read the blueprint, is to write off the four-mark domains. Resist it, for two reasons.
First, the arithmetic. The pass mark is set by test equating rather than a fixed percentage, and it has recently sat around the mid-sixties as a proportion of scored questions. In that territory, single-figure domains are not rounding errors. Four marks in ophthalmology and eight in dermatology together approach the margin that separates many candidates from a pass.
Second, the economics. Small domains are bounded. You cannot finish cardiology, but you can genuinely finish the ophthalmology likely to appear in an MRCP paper in a few focused sessions. The return per hour in those domains is unusually high, precisely because the content is finite and the questions tend to be drawn from a predictable core.
Do not neglect what crosses the specialties
One last category deserves protecting: the concepts that belong to no chapter but appear everywhere. Acid-base disturbance, fluid and electrolyte physiology, and the pharmacological principles behind common drug interactions turn up embedded in cardiology, nephrology, respiratory and endocrine questions alike.
Because they are not owned by a specialty, they get revised nowhere. Because they appear across specialties, they are worth far more than any single topic. Practise them deliberately in mixed blocks, and treat a recurring acid-base error as one problem rather than as three separate specialty weaknesses.
Where iatroX fits
iatroX's MRCP Part 1 bank is mapped to the Federation blueprint with the same unequal weighting the exam uses, and it supports the sequence above directly: Standard mode for the coverage audit that exposes your unknowns rather than merely your weaknesses, an adaptive engine that then targets the domains where you are genuinely weak, and spaced repetition for the clinical sciences content that decays fastest. Explanations are grounded in current guidance, and missed questions can be opened in the Socratic Tutor, which asks you to reason before it explains. Try it with free sample questions at iatroX. For the mechanism-heavy content that dominates clinical sciences, see rebuilding basic science for MRCP Part 1.
Frequently asked questions
How is the MRCP Part 1 blueprint weighted? Unequally, and the distribution is published by the Federation. Major specialties such as cardiology, neurology, gastroenterology and respiratory medicine carry roughly fifteen questions each across the two papers, while ophthalmology, dermatology and psychiatry carry considerably fewer.
What is the largest single component of MRCP Part 1? Clinical sciences, which bundles pharmacology, statistics, genetics, immunology, physiology and biochemistry. It carries more marks than any individual clinical specialty, and because no rotation teaches it, it is the most commonly under-revised part of the exam.
Should I skip the low-weighted specialties? No. With the pass mark typically around the mid-sixties as a proportion of scored questions, single-figure domains still matter, and they are cheap to secure because the content is bounded. You cannot finish cardiology, but you can realistically finish MRCP-level ophthalmology.
When should I switch from broad coverage to adaptive practice? Once you have representative exposure across the whole blueprint. An adaptive engine can only target weaknesses it has observed, so running it before you have sampled broadly produces a well-optimised tour of the topics you already do.